Clinical Trial Update: A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on how TAK-881 is processed by the body and its side effects in people with Primary immunodeficiency diseases, across Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency Diseases

Drugs mentioned

• TAK-881

Snippet

Sponsor: Takeda | Conditions: Primary Immunodeficiency Diseases (PID) | Phase 2, Phase 3 | Status: COMPLETED